Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
Esperion (NASDAQ: ESPR) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference scheduled for Thursday, December 5, 2024, at 12:30 p.m. ET. The event will be webcasted and accessible through Esperion's investor and media section website, with replay available approximately two hours after completion and archived for 90 days.
Esperion focuses on developing innovative medicines for cardiovascular and cardiometabolic diseases, particularly targeting high cholesterol. The company aims to support healthcare providers in reducing LDL-cholesterol levels effectively, addressing the needs of millions of patients whose health requirements are not met by current standards.
Esperion (NASDAQ: ESPR) ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler programmata per giovedì 5 dicembre 2024, alle 12:30 ET. L'evento sarà trasmesso in streaming e sarà accessibile attraverso la sezione dedicata agli investitori e ai media sul sito di Esperion, con una registrazione disponibile circa due ore dopo la conclusione e archiviata per 90 giorni.
Esperion si concentra nello sviluppo di medicinali innovativi per le malattie cardiovascolari e cardiometaboliche, con particolare attenzione all'ipercolesterolemia. L'azienda mira a supportare i fornitori di assistenza sanitaria nella riduzione efficace dei livelli di LDL-colesterolo, affrontando le esigenze di milioni di pazienti le cui necessità sanitarie non sono soddisfatte dagli attuali standard.
Esperion (NASDAQ: ESPR) ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler, programada para el jueves 5 de diciembre de 2024, a las 12:30 p.m. ET. El evento será transmitido en línea y se podrá acceder a través de la sección de inversionistas y medios en el sitio web de Esperion, con una repetición disponible aproximadamente dos horas después de la conclusión y archivada por 90 días.
Esperion se enfoca en desarrollar medicamentos innovadores para enfermedades cardiovasculares y cardiometabólicas, apuntando particularmente al colesterol alto. La empresa tiene como objetivo ayudar a los proveedores de atención médica a reducir eficazmente los niveles de colesterol LDL, atendiendo las necesidades de millones de pacientes cuyas necesidades de salud no se satisfacen con los estándares actuales.
Esperion (NASDAQ: ESPR)는 Piper Sandler 제36회 연례 헬스케어 컨퍼런스에 참석한다고 발표했습니다. 이 행사는 2024년 12월 5일 목요일 오후 12시 30분 ET에 예정되어 있습니다. 이 행사는 웹캐스트로 진행되며 Esperion의 투자자 및 미디어 섹션 웹사이트를 통해 접근할 수 있으며, 완료 후 약 두 시간 후에 다시 볼 수 있고 90일 동안 보관됩니다.
Esperion은 심혈관 및 심혈관 대사 질환을 위한 혁신적인 약품 개발에 집중하고 있으며, 특히 고콜레스테롤을 겨냥하고 있습니다. 이 회사는 현재 표준으로 충족되지 않는 건강 요구를 가진 수백만 환자의 요구를 해결하기 위해 의료 제공자가 LDL 콜레스테롤 수치를 효과적으로 줄일 수 있도록 지원하는 것을 목표로 하고 있습니다.
Esperion (NASDAQ: ESPR) a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler, prévue pour le jeudi 5 décembre 2024, à 12h30 ET. L'événement sera diffusé en direct et accessible via la section investisseurs et médias du site d'Esperion, avec un replay disponible environ deux heures après la fin et archivé pendant 90 jours.
Esperion se concentre sur le développement de médicaments innovants pour les maladies cardiovasculaires et cardiométaboliques, en ciblant particulièrement le cholestérol élevé. L'entreprise vise à soutenir les prestataires de soins de santé dans la réduction efficace des niveaux de LDL-cholestérol, répondant ainsi aux besoins de millions de patients dont les exigences sanitaires ne sont pas satisfaites par les normes actuelles.
Esperion (NASDAQ: ESPR) hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler angekündigt, die am Donnerstag, den 5. Dezember 2024, um 12:30 Uhr ET stattfinden wird. Die Veranstaltung wird per Webcast übertragen und ist über den Bereich für Investoren und Medien auf der Website von Esperion zugänglich, mit einer Wiederholung, die etwa zwei Stunden nach Ende der Veranstaltung verfügbar ist und für 90 Tage archiviert wird.
Esperion konzentriert sich auf die Entwicklung innovativer Medikamente zur Behandlung von Herz-Kreislauf- und kardiometabolischen Erkrankungen, wobei ein besonderer Schwerpunkt auf hohem Cholesterin liegt. Das Unternehmen hat es sich zum Ziel gesetzt, Gesundheitsdienstleister dabei zu unterstützen, die LDL-Cholesterinwerte effektiv zu senken und die Bedürfnisse von Millionen von Patienten zu adressieren, deren Gesundheitsanforderungen von den aktuellen Standards nicht erfüllt werden.
- None.
- None.
ANN ARBOR, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024, at 12:30 p.m. ET.
The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.
Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.
Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903
Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438
FAQ
When is Esperion (ESPR) presenting at the Piper Sandler Healthcare Conference 2024?
How long will Esperion's (ESPR) webcast replay be available?
What is Esperion's (ESPR) main focus in healthcare?
How can investors access Esperion's (ESPR) Piper Sandler conference presentation?
